Maribavir
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 333 publications
A novel inhibitor of human cytomegalovirus acts through a specific antiviral mechanism that involves the helicase-primase complex.
Journal: Antimicrobial agents and chemotherapy
Published: July 13, 2026
Maribavir in lung transplant recipients with cytomegalovirus infection: real-life experience.
Journal: Infection
Published: June 22, 2026
Real-World Use of Maribavir for Refractory CMV Infection and Intolerance to Conventional Anti-CMV Agents After Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: May 07, 2026
Targeting the US21 viroporin of human cytomegalovirus by calcium channel blockers as a new antiviral strategy.
Journal: Current research in microbial sciences
Published: May 04, 2026
Epidemiology and clinical management of cytomegalovirus infection in transplant recipients in Central and Eastern Europe - a physician survey.
Journal: Antiviral therapy
Published: April 29, 2026
Intravitreal foscarnet is an effective adjunct after systemic therapy failure in pediatric antiviral-resistant cytomegalovirus retinitis.
Journal: The Journal of international medical research
Published: April 16, 2026
Maribavir for cytomegalovirus retinitis: A case series and review of the literature.
Journal: AJO international
Published: April 06, 2026
Drug interaction between maribavir and rifampin: a case report.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 28, 2026
The Troll Is Weakened but Not yet Defeated: An Update on Cytomegalovirus Management in Transplantation From the International CMV Symposium 2025.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: March 23, 2026
Case report:Maribavir for refractory CMV infection in 2 pediatric HSCT recipients.
Journal: Diagnostic microbiology and infectious disease
Published: March 23, 2026
Analysis of healthcare resource utilization before and after initiation of maribavir for cytomegalovirus treatment.
Journal: Journal of medical economics
Published: March 11, 2026
Case report: Maribavir as salvage therapy for multidrug-resistant CMV DNAemia in a non-transplant patient with ocular cicatricial pemphigoid.
Journal: IDCases
Published: March 07, 2026
Last Updated: 09/26/2026